BioCryst Pharmaceuticals Ownership | Who Owns BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals Ownership Summary
BioCryst Pharmaceuticals is owned by 18.57% institutional investors, 1.19% insiders, and 80.24% retail investors. Vanguard group is the largest institutional shareholder, holding 10.42% of BCRX shares. BioPharma Credit Ord is the top mutual fund, with 8.23% of its assets in BioCryst Pharmaceuticals shares.
BCRX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | BioCryst Pharmaceuticals | 18.57% | 1.19% | 80.24% |
| Sector | Healthcare Stocks | 42.54% | 10.83% | 46.63% |
| Industry | Biotech Stocks | 45.22% | 10.75% | 44.04% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vanguard group | 21.79M | 10.42% | $165.39M |
| Blackrock funding, inc. /de | 21.25M | 10.16% | $161.26M |
| Blackrock | 19.96M | 9.68% | $123.33M |
| Deerfield management company, l.p. (series c) | 12.17M | 5.82% | $92.36M |
| State street | 9.81M | 4.69% | $74.44M |
| Kynam capital management, lp | 9.39M | 4.49% | $71.27M |
| Ubs group | 5.97M | 2.85% | $45.30M |
| Alkeon capital management | 5.46M | 2.61% | $41.47M |
| Arrowstreet capital, limited partnership | 5.23M | 2.50% | $39.67M |
| Morgan stanley | 5.20M | 2.49% | $39.49M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Rp management | 3.85M | 12.84% | $29.23M |
| Kynam capital management, lp | 9.39M | 5.31% | $71.27M |
| Deerfield management company, l.p. (series c) | 12.17M | 1.41% | $92.36M |
| Parkman healthcare partners | 1.01M | 0.80% | $7.69M |
| Rice hall james & associates | 1.88M | 0.78% | $14.27M |
| Rock springs capital management lp | 2.68M | 0.77% | $20.14M |
| Eversept partners, lp | 1.37M | 0.72% | $10.43M |
| Qtr family wealth | 157.14K | 0.57% | $1.19M |
| Doliver advisors, lp | 274.33K | 0.54% | $2.08M |
| Semanteon capital management, lp | 43.54K | 0.41% | $330.50K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Deerfield management company, l.p. (series c) | 12.17M | 1.41% | 7.48M |
| Hood river capital management | 3.62M | 0.32% | 2.38M |
| Jane street group | 1.85M | 0.00% | 1.57M |
| Blackrock | 19.96M | 0.00% | 1.52M |
| State street | 9.81M | 0.00% | 1.30M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Braidwell lp | - | - | -3.38M |
| Avoro capital advisors | 1.25M | 0.12% | -3.25M |
| Walleye capital | 227.06K | 0.01% | -2.07M |
| Voloridge investment management | 957.02K | 0.02% | -1.52M |
| Nuveen asset management | 3.42M | 0.01% | -1.40M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Cubist systematic strategies | 1.25M | 0.05% | 1.25M | $9.46M |
| Orbimed advisors | 901.50K | 0.16% | 901.50K | $6.84M |
| Norges bank | 524.80K | 0.00% | 524.80K | $3.95M |
| Bridgewater associates, lp | 411.50K | 0.01% | 411.50K | $3.12M |
| Nebula research & development | 286.51K | 0.22% | 286.51K | $2.57M |
Sold Out
| Holder | Change |
|---|---|
| Tfo-tdc | -3.00 |
| Financial gravity asset management | -8.00 |
| Newedge advisors | -11.00 |
| Dinuzzo private wealth | -13.00 |
| Newbridge financial services group | -15.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 101 | -65.88% | 38,849,402 | -78.37% | 18 | 0.25% | 42 | -73.58% | 35 | -57.83% |
| Jun 30, 2025 | 304 | 9.35% | 196,946,754 | 15.72% | 94 | 1.42% | 161 | 5.92% | 86 | 30.30% |
| Mar 31, 2025 | 277 | 2.59% | 174,118,175 | 3.86% | 83 | 1.27% | 150 | 29.31% | 66 | -25.00% |
| Dec 31, 2024 | 265 | -1.49% | 167,630,080 | -2.81% | 81 | 1.17% | 114 | -14.29% | 87 | 17.57% |
| Sep 30, 2024 | 268 | 7.63% | 172,429,027 | -1.07% | 83 | 1.17% | 134 | 5.51% | 73 | 8.96% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| BioPharma Credit Ord | 17.22M | 8.23% | 17.22M |
| Vanguard US Total Market Shares ETF | 6.57M | 3.14% | -18.55K |
| Vanguard Total Stock Mkt Idx Inv | 6.59M | 3.14% | -139.50K |
| iShares Russell 2000 ETF | 5.04M | 2.40% | - |
| SPDR® S&P Biotech ETF | 3.67M | 1.75% | 8.19K |
| ACAP Strategic A | 2.82M | 1.34% | -727.21K |
| Vanguard Small Cap Index | 2.54M | 1.21% | -17.21K |
| Vanguard Institutional Extnd Mkt Idx Tr | 2.25M | 1.07% | -987.45K |
| Fidelity Small Cap Index | 2.10M | 1.00% | 5.33K |
| iShares Russell 2000 Growth ETF | 1.84M | 0.88% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 02, 2025 | Barnes Alane P | Chief Legal Officer | Sell | $367.22K |
| Dec 01, 2025 | Barnes Alane P | Chief Legal Officer | Sell | $646.51K |
| Dec 03, 2025 | Barnes Alane P | Chief Legal Officer | Sell | $151.24K |
| Nov 13, 2025 | SANDERS MACHELLE | - | Sell | $68.54K |
| Aug 13, 2025 | HEGGIE THERESA | - | Sell | $595.87K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | 4 |
| 2025 Q3 | - | 1 |
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
| 2024 Q4 | - | 1 |
BCRX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools